Psilocybin, the psychedelic substance found in magic mushrooms, is a promising new treatment for psychiatric disorders, ...

A quarter of all adults in Scotland are now being prescribed antidepressant drugs as the country is gripped by an ...

A recent study has revealed that about one in six people who stop taking antidepressants may face withdrawal symptoms. These ...

Although nighttime depression can be a symptom of clinical depression, research suggests that most people, including those ...

Whether abusive parents, drug addiction or gun violence are to blame, the fallout from childhood traumas can reverberat ...

Classic psychedelics, some advocates argue, come with too much baggage. But these altered, “next generation” medications may ...

When I was first diagnosed with bipolar disorder, medication was the last thing I wanted. The major reason was the stigma ...

A recent study published in the Journal of Psychopharmacology suggests that psilocybin, the psychoactive compound found in ...

The buying interest in the stock came after the company announced positive topline results from its Phase-2a trials aimed at assessing the safety and efficacy of Ropanicant, a drug developed to treat ...

The open-label study, involving 41 patients across 10 US sites, demonstrated statistically significant improvements in depressive symptoms as measured by the Montgomery-Asberg Depression Rating ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.